TRU-SENTIMENT ยท DeltaNeutral
DHR Trading Analysis - 10/26/2026 10:14 AM โ TRU-SENTIMENT
Options chain ยท Stock chart ยท Baseline chart
DHR (Danaher Corporation) at $232.07. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $31,080 vs put $0. RSI 59.6.
- Symbol
- DHR
- Price
- $232.07
- Article bias (separate from True Sentiment)
- bullish
- Conviction
- medium
- Published
- 2026-10-26 10:14:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)Based on embedded TRUE SENTIMENT OPTIONS data (2026-10-26):
Call Dollar Volume: $31,080.00 (100.00%) Put Dollar Volume: $0.00 (0.00%) Total: $31,080.00
Overall sentiment: Bullish. Pure directional conviction (Delta 40-60 filter) shows 9 call trades, 0 put trades, 27 call contracts. This indicates unanimous directional buying with no put hedge in the filtered set. Near-term expectations: upward bias into 2026-11-20 expiration. No divergence from technicals (both bullish); however, low total dollar volume ($31,080) implies small sample conviction.
Key Statistics: DHR
Fundamental Snapshot
Valuation
| P/E (trailing) | 39.60 |
| EPS (trailing 12 mo) | $5.66 |
| Market cap | $162.94B |
| Shares outstanding | 703.0M |
Dividend
| Dividend yield | 0.71% |
| Annual dividend | $1.60 |
| Ex-dividend date | 2026-09-30 |
Risk & range
| Beta | 0.58 |
| 52-week low | $160.93 |
| 52-week high | $242.80 |
| Historical volatility | 30.4% |
Ownership & trading
| Institutional ownership | 63.2% |
| Average daily volume | 4.9M sh |
Reported figures; no analyst estimates.
๐ Analysis
News Headlines & Context
Danaher Corporation (DHR) has seen several recent developments that provide context for the trading data below. The following items are based on general knowledge and are separated from the data-driven analysis:
- DHR completed a previously announced spin-off of its environmental and applied solutions segment earlier in 2026, streamlining focus on life sciences and diagnostics.
- Management cited steady demand in bioprocessing and instrumentation during recent industry conferences, though tariff sensitivity on imported components remains a talking point.
- The company paid its quarterly dividend with ex-dividend date of 2026-09-30, reflected in fundamentals data provided.
- No major earnings catalyst is scheduled before the next major options expiration of 2026-11-20 per general knowledge; Q3 FY2025 earnings occurred prior to the embedded data window.
- Broader medtech M&A chatter has kept large-cap instrument names like DHR in focus, potentially supporting institutional accumulation seen in fundamentals (63.21% institutional).
Context: The constructive headlines around portfolio simplification and steady end-markets align with the bullish options flow and upward SMA structure in the embedded data, though valuation remains rich.
Fundamental Analysis
Based strictly on the provided FUNDAMENTALS data for DHR as of 2026-10-26:
| Metric | Value |
|---|---|
| Trailing P/E | 39.60 |
| Trailing EPS | 5.66 |
| Market Cap | 162,938,095,080.00 |
| Shares Outstanding | 702,986,000.00 |
| Dividend Yield | 0.71% |
| Dividend Rate | 1.60 |
| Beta | 0.58 |
| 52-Week High | 242.80 |
| 52-Week Low | 160.93 |
| Institutional % | 63.21% |
| Average Volume | 4,868,000.00 |
| Historical Volatility | 30.37% |
Revenue growth (YoY), profit margins (gross/operating/net), return on equity, debt-to-equity, free cash flow, PEG ratio, price-to-book, and total revenue are not available in the embedded fundamentals (all null). The trailing P/E of 39.60 is elevated versus typical industrial peers; however, the provided data includes no sector P/E or PEG for comparison. The forward P/E and target mean price are also null, so no analyst consensus context can be drawn from the data.
Key strength: low beta (0.58) implies relative downside protection versus market; high institutional ownership (63.21%) signals professional sponsorship. Concern: rich absolute valuation (39.60 P/E) with no margin or growth data to justify continuation. Fundamentals show stability but diverge from the bullish technical momentum in that price is near 52-week high (242.80) while fundamental depth is undisclosed.
Current Market Position
Current price per indicators: $229.50 (as of 2026-10-23 close). Minute bars show session open 2026-10-26 at $230.94, high $233.69, low $230.94, close at 09:45 $232.08 with volume building to 105,165 at 09:30. Last weekly close 2026-10-23 was $229.50 after intraday range $225.60โ$229.62.
Recent price action: Daily history shows rally from $203.25 (2026-09-14) to $238.13 high (2026-10-22), with pullback to $229.50. The 30-day range is $199.09โ$238.13.
Intraday momentum: Opening 2026-10-26 jumped to $232.88 then dipped to $230.60 by 09:40 before recovering to $232.08 at 09:45, indicating buyer support above $230.00.
Technical Analysis
Technical Indicators
SMA alignment: Price ($229.50) > SMA 5 ($228.29) > SMA 20 ($223.24) > SMA 50 ($216.14). No bearish crossovers; bullish stack intact. RSI 59.59 shows moderate momentum, not overbought (<70). MACD histogram positive (0.85) confirms bullish momentum. Bollinger Bands: price within upper half, below upper band ($234.57) โ no squeeze (bands wide at $211.90โ$234.57). 30-day range: price at $229.50 is 78.4% of range from low ($199.09) to high ($238.13), indicating upper-third positioning.
True Sentiment Analysis (Delta 40-60 Options)
Based on embedded TRUE SENTIMENT OPTIONS data (2026-10-26):
Call Dollar Volume: $31,080.00 (100.00%) Put Dollar Volume: $0.00 (0.00%) Total: $31,080.00
Overall sentiment: Bullish. Pure directional conviction (Delta 40-60 filter) shows 9 call trades, 0 put trades, 27 call contracts. This indicates unanimous directional buying with no put hedge in the filtered set. Near-term expectations: upward bias into 2026-11-20 expiration. No divergence from technicals (both bullish); however, low total dollar volume ($31,080) implies small sample conviction.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.